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SUMMARY 
Inhaler device modifications directly influence aerosol generation mechanisms, so 
the development of inhalation products could be advanced effectively if the relevant 
processes can be studied in situ.  However, the ability to visualize, in real time, 
atomization in a metered dose inhaler (MDI) or fluidization in a dry powder inhaler 
(DPI) remains challenging. This article reviews high-speed imaging, fluorescence 
imaging, particle image velocimetry (PIV) and phase-doppler anemometry (PDA) and 
demonstrates how these techniques can be used to characterize aerosol clouds 
whilst they are being generated and reveal the nature of aerosol production 
processes as they unfold inside inhaler devices.  The different optical diagnostics 
generate complementary data including aerosol droplet size, velocity and overall 
aerosol/spray attributes.  Understanding the details of transient events during 
metering of a drug dose into the inhaled airflow at the appropriate temporal and 
spatial resolution creates opportunities for targeted interventions to solve problems 
e.g. excessive device deposition.  Moreover, the images generated by optical 
techniques represent a readily accessible form of information which supports multi-
disciplinary collaboration, so, when using optical diagnostics, we can legitimately 
claim that “Seeing is Believing”.   
 
INTRODUCTION 
The key parameters that determine the aerodynamic performance of an inhalation 
product are the aerosol particle size and the particle size distribution.  Cascade 
impaction is the preferred measurement approach, because it is API specific and 
measures the entire cloud, but the technique is labor intensive, complicated to use 
and, therefore, prone to operator errors [1].  Moreover, the particle size distribution 
measured using a cascade impactor represents the end of a dynamic transport 
process that may itself induce specific changes.   
Without adequate knowledge of the processes responsible for primary aerosol 
generation and drug deposition and without deeper understanding of aerosol 
behaviour during transport, device design is unlikely to proceed in an optimal way.  
In this paper, we review the application of high-speed imaging, fluorescence 
imaging, particle image velocimetry (PIV) and phase-doppler anemometry (PDA) to 
characterize inhalation devices.  These optical techniques are used to study MDI 
sprays and DPI aerosols and the processes leading to device drug deposition and 
identify opportunities for the wider application of these research techniques to device 
development.  
 
High-speed Imaging and Digital Image Analysis  
Imaging systems such as Envision Pharma (Oxford Lasers, Shirley, MA, USA) and 
ISI5000 (InnovaSystems, Mooretown, NJ, USA) are widely utilized in the 
pharmaceutical industry to characterize spray patterns and plume geometry of MDIs 
and nasal sprays.  Laser sheet illumination, perpendicular to the spray centreline, is 
used for spray pattern analysis in quality control testing recommended by FDA 
guidelines [2].  Geometric properties of the cross-section of the developing aerosol 
cloud, such as diameter, centroid and ellipticity, are found by means of digital image 
analysis.  Laser sheet illumination along the spray centreline can image the plume 
geometry, which is recommended by the FDA, during product development [2].  This 
optical arrangement enables the characterization of spray cone angle, plume width 
and spray direction relative to the orifice centreline.  The SprayVIEW® (Proveris 
Scientific, Marlborough, MA, USA) patternation system has been used to investigate 
the effect of MDI geometry on spray patterns in conjunction with laser diffraction for 
particle sizing [3].  Spray patterns and particle size were both found to be sensitive to 
actuator orifice diameter, length and sump depth, providing evidence that spray 
pattern analysis can be useful during product development.   
Imaging of inhaler devices and their aerosol plumes is beneficial, because it 
provides large amounts of visual information in a very accessible form.  To capture 
sufficient detail, imaging systems must be able to freeze the motion of micron-size 
small particles that move at high speeds, which is achieved using high-power 
Nd:YAG or Cu-vapor lasers producing 10-20 ns pulses at frequencies up to 20 kHz 
as the light source.  A planar sheet is formed from a pencil beam of laser light using 
a cylindrical lens, which can be directly used for light sheet illumination or to pump 
light into a dye cell to generate a uniform source of backlighting.  High-speed digital 
cameras, such as the 1 Mpixel Fastcam SA (Photron, San Diego, CA, USA), are 
synchronized to the laser pulse frequency to capture the flow images.  The camera is 
equipped with suitable macro-lenses to magnify regions of interest where newly 
formed aerosols emerge from a device mouthpiece or liquid atomization / powder 
fluidization takes place.   
The flow and spray generation mechanism inside a transparent model of a 
novel MDI actuator with a vortex nozzle (Kos Pharmaceuticals, Morrisville, NC, USA) 
was imaged using a Kodak HS4540 digital high-speed camera and Cu-vapor pulsed 
laser illumination [4].  Large droplet production and high drug deposition for the 
standard vortex nozzle assembly (VNA) were found to be associated with the 
formation of a liquid pool on the surfaces of the nozzle exit cone during the spray 
event.  Subsequent evaporation of the propellant left a large drug residue (Figure 1).  
This observation led to design changes including the removal of the exit cone, which 
virtually eliminated drug deposition in the nozzle exit region of the optimized vortex 
nozzle [4].   
High-resolution, high-speed imaging has also been used to study the 
fluidization of lactose placebo formulations and aerosol plumes just outside the 
mouthpiece of Nexthaler® DPI (Chiesi Farmaceutici, Parma, Italy) [5].  The operation 
of the dose protector in the device was revealed, as well as details of the transient 
powder fluidization process.  Analysis of the digital images of the aerosol near the 
mouthpiece gave precise information relating to the timings of key fluidization events 
after the start of inhalation.  The main fluidization event was found to be subdivided 
into two stages: (i) a short, dense initial pulse of 15-25 ms duration with the large 
bulk of the particle dose released and (ii) a second, slightly overlapping pulse of 50+ 
ms duration with particles that were released more slowly by the device.   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
While digital image analysis can provide detailed and quantitative 
understanding of the powder dose release characteristics of DPIs, a major drawback 
of scattered light imaging is that the bulk of the powder formulation is carrier material 
not API. A new imaging technique has recently been proposed to study the release 
of fines based on fluorescence imaging [6].  The method employs a model API 
system consisting of fluorescent microspheres (Cospheric, Santa Barbara, CA, USA) 
manufactured from a proprietary polymer with a diameter range of 1-5 µm (D50 = 2 
µm).  The microspheres have a peak fluorescent emission of 607 nm under 
excitation by laser light with a wavelength of 527 nm.  They are blended with 
Figure 1: Images of nozzle exit region (a-b) and contour maps of whole-actuation-
averaged velocity at the mouthpiece exit (c-d) of standard vortex nozzle assembly 
(VNA) and optimized VNA. Reproduced with permission from [4] 
a b 
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proprietary lactose carrier before loading into the Nexthaler DPI.  Figure 2 illustrates 
the aerosol plume in the vicinity of the device mouthpiece utilizing a two-camera 
system (Photron, San Diego, CA, USA) for simultaneous imaging of scattered light 
and fluorescent emission.  One of the cameras is equipped with a short pass filter ( 
< 607 nm) to image scattered light representing all the powder and the other camera 
equipped with a long-pass optical filter (with  > 527 nm) to record fluorescent 
emission from model API microspheres only.  Comparison of the images highlights 
differences between the distribution of the microspheres and the powder.  Detailed 
analysis of the fluorescent images showed that the bulk of the microspheres are 
released during the short initial peak along with the bulk of the powder dose. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Sample images of laser-induced fluorescence and scattered light 
comparing the distribution of microspheres and the carrier powder  
Particle Image Velocimetry (PIV)  
Spray patternation has been used to estimate the velocity of the expanding aerosol 
by tracking the front of MDI sprays [7] and Respimat® soft-mist inhaler [8], 
respectively.  Spray front tracking provides useful indications of the velocity of 
transient spray events, but the spray front is not representative of the spray as a 
whole.  Two- and three-dimensional velocity vector fields can be measured using 
high-speed imaging in conjunction with a digital image analysis technique called 
particle image velocimetry (PIV).  Briefly, a laser sheet illuminates a fluid region of 
interest.  In 2D PIV, double-pulsed lasers are synchronized with the shutter opening 
of one digital camera perpendicular to the laser sheet to record pairs of images of 
moving particles in the laser sheet at a known time separation [9].  After recording, 
the image pairs are analyzed off-line to determine the velocity field.  Each image pair 
is subdivided into analysis sub-regions (e.g. 32x32 pixels).  Groups of particles that 
move with the flow will be located at slightly different positions in the two images.  
PIV image processing algorithms seek the highest correlation between pairs of sub-
region images to identify the most probable displacement of groups of particles.  This 
displacement divided by time interval between the laser pulses gives the x- and y-
components of the in-plane velocity vector describing the average particle motion 
within the chosen sub region.  The analysis is repeated over the entire image to build 
up a spatially resolved two-dimensional velocity vector map (Figure 3).   
Stereoscopic systems use two cameras recording at 45o angles to the laser 
sheet to make it possible to reconstruct all three components of the velocity vector of 
spray particles in the plane of the laser sheet [9].  All these systems are 
commercially available (e.g. Dantec Dynamics, Skovlunde, Denmark; LaVision, 
Figure 3: Typical PIV velocity vector map of flow induced by a MDI spray event 
showing pulsatile behaviour and entrainment of ambient air by the spray plume 
Göttingen, Germany; TSI, Shoreview, MN, USA), including tomographic PIV or thick-
sheet PIV for full 3D (whole-volume) velocity vector mapping.   
 
 
 
 
 
 
 
 
 
The plume characteristics of a HFA budesonide solution MDI were compared with 
those from a CFC budesonide suspension MDI using PIV measurements via a USP 
throat, using windows for optical access [10]. The observed flow fields were 
correlated with deposition patterns in the USP throat, which were found to be 
concentrated in the horizontal section of the USP throat rather than high velocity 
particles impacting at the back. This implies particle dispersion by turbulent flow 
followed by deposition. A comprehensive study of the spray and flow induced by 
firing commercial salbutamol sulphate / HFA 134a MDIs using PIV velocity maps 
outside the mouthpiece [11] revealed the complex temporal and spatial structure of 
the spray flow.  Velocity distributions were shown to have a Gaussian radial 
distribution with decaying centreline velocity and widening spray with distance due to 
friction between the spray plume and the surrounding air.  Substantial variations of 
the spray cone angle were observed, which were correlated with variations of the 
spray direction relative to the spray orifice centreline.   
 Phase-Doppler Anemometry (PDA) 
Phase-Doppler Anemometry is an optical technique for simultaneous measurement 
of particle velocity and size, at a point.  A laser beam is divided into two by a beam 
splitter and the beams focused and crossed to form a small probe volume (typically 
100 m diameter).  Light scattered by particles travelling through the probe volume is 
modulated by a Doppler frequency fD that is proportional to the velocity component U 
of the particle in the plane of the crossing laser beams and perpendicular to their 
bisector.  The scattered light is collected by means of photomultiplier tubes.  It can 
also be shown that the phase difference 1-2 between scattered light signals 
travelling along slightly different paths to two or more separate detectors is 
proportional to the size d of the scattering particle [12].  Different signal processing 
methods are available to compute the particle velocity and size for a given optical 
arrangement.   
The earliest comprehensive study of MDI aerosols using PDA surveyed the 
spray velocity and droplet size distributions of MDIs with placebos and commercial 
CFC and HFA formulations [13]. PDA was used to determine “whole-actuation-
averaged” values of velocity (see Figure 1) and droplet size outside the mouthpiece 
of pMDI sprays produced by a standard vortex nozzle and an optimized design [4, 
14].  The experiments showed that the optimized vortex nozzle produced reduced 
particle deposition in the device and USP throat without changing the average spray 
plume velocity.   
A Dantec 1D-PDA system (Dantec Dynamics, Skovlunde, Denmark) was 
used to determine the axial velocity and droplet size for nine MDI products including 
CFC and HFA formulations [15].  The work confirmed the ability of the instrument to 
discriminate velocity differences between individual products, but droplet size 
comparisons produced inconclusive.   
A two-component PDA system using an argon-ion laser with strong emission 
lines at green and blue wavelengths 532 nm and 379 nm, respectively has been 
described [16].  Two beam pairs are intersected in perpendicular planes at the same 
measurement point to allow simultaneous measurement of two velocity components 
and droplet size by equipping photomultipliers with suitable optical filters.  Figure 4 
illustrates PDA surveys of a HFA227 placebo aerosol.  Temporal distributions of 
droplet velocity and number mean droplet size D10 of a HFA227 placebo aerosol are 
shown at 10 radial sampling points across the actuator mouthpiece.  These were 
analyzed in time bins with a width of 5 ms to reveal details of the temporal behavior.  
The D10 value varied considerably as a function of time and radial position.  A 
discrete event that is responsible for the production of many large droplets in distinct 
local areas is evident during the first 100 ms of the spray event.   
 
 
 
 
 
 
 
 
Measurements were also undertaken in the near-orifice region at an axial 
distance of 2.6 mm from the spray orifice of a modified actuator equipped with 
windows for optical access [16].  The radial velocity component was also obtained, 
(a) Mean droplet velocity (b) Number mean drop size D10 
Figure 4: Results of PDA survey of HFA227 placebo spray across 
mouthpiece exit of a prototype actuator 
Large droplet 
production event 
which revealed considerable variations of the spray direction with time.  It was found 
that considerable care must be taken to make measurements at a sufficient number 
of locations to ensure that a representative sample of the MDI aerosol plume is 
obtained.  Recently, the droplet size and velocity distributions of HFA134-ethanol 
placebo sprays generated from a Bespak actuator were examined using a new 
systematic test protocol [17].  The sprays velocities with 0, 10 and 20% w/w of 
ethanol were found to be similar (26.51.5 m/s) during the main phase of the spray 
event when 95% of the measured droplet mass was emitted by the MDI [18].  The 
number mean droplet size (3.30.5 m) was found to increase with ethanol content, 
whereas the Sauter mean diameter was much higher for pure HFA134 (16.9 m) 
than for the formulations containing ethanol (6.1 and 7.6 m for 10 and 20% w/w 
ethanol, respectively).  High-speed imaging in transparent models showed significant 
differences of the flow regime in the actuator sump.  Again, optical diagnostics were 
able to highlight the probable causes of subtle differences of the droplet size for 
formulations, with and without ethanol.  The findings suggested that the state of the 
flow at the spray orifice entrance, which is governed by gravity, viscous and surface 
tension effects, might play a role in controlling MDI spray droplet size distributions.   
 
Discussion and Conclusions 
Cascade impaction measurements of aerodynamic particle size distributions of 
pharmaceutical aerosols take place at a distance from the source of the aerosol, 
which does not provide insight into the underlying processes. Without this 
fundamental understanding, device design for new products generally involves the 
adaptation of existing platforms by means of trials guided by past experience. Device 
modifications directly influence aerosol generation, so the study of aerosol 
production at source is likely to be more beneficial to guide device development. 
Different optical diagnostics have been shown to generate complementary, and 
mutually reinforcing, information. For example, PIV and PDA data provide 
information relating to aerosol droplet size and velocity, which both affect unwanted 
drug deposition. PIV yields whole-field time-resolved velocity information at modest 
spatial resolution. PDA, on the other hand, generates the temporal behavior of 
particle size and velocity simultaneously on a point-by-point basis. Droplets and 
particles smaller than (say) 5-10 m are usually below the diffraction limit of a typical 
imaging setup, so these appear blurred in imagery. Phase-doppler anemometry, 
however, is highly suited to the measurement of such small particles. Larger 
particles and droplets can be imaged individually and their shape can be determined 
if the magnification is sufficient and the pixel grid of the digital camera has high 
resolution. Such large particles are often undesirable for inhalation therapy and a 
good visual indication can be a first step towards understanding the processes that 
produce them.  Having identified and localized these problematic contributions to the 
final particle size distribution - there may be opportunities for design improvements 
targeted at their elimination. It is difficult to imagine how such insight could be 
obtained using performance characterization with impactor measurements only.  
Finally, optical techniques generate quantitative data as well as still images and 
videos. In our work, we have found that the joint interpretation of visualization 
material is a very fruitful activity in multi-disciplinary collaborations. By using optical 
diagnostics we can legitimately claim “Seeing is Believing”.   
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